Influence of androgen receptor in vascular cells on reperfusion following hindlimb ischaemia by Wu, Junxi et al.
RESEARCH ARTICLE
Influence of Androgen Receptor in Vascular
Cells on Reperfusion following Hindlimb
Ischaemia
Junxi Wu1,2, Patrick W. F. Hadoke2, Kaloyan Takov2, Agnieszka Korczak2, Martin
A. Denvir2, Lee B. Smith1*
1 MRCCentre for Reproductive Health, University of Edinburgh, The Queen's Medical Research Institute, 47
Little France Crescent, Edinburgh, EH16 4TJ, United Kingdom, 2 University/ BHF Centre for Cardiovascular
Science, University of Edinburgh, The Queen's Medical Research Institute, 47 Little France Crescent,




Studies in global androgen receptor knockout (G-ARKO) and orchidectomised mice sug-
gest that androgen accelerates reperfusion of the ischaemic hindlimb by stimulating angio-
genesis. This investigation used novel, vascular cell-specific ARKOmice to address the
hypothesis that the impaired hindlimb reperfusion in G-ARKOmice was due to loss of AR
from cells in the vascular wall.
Methods and Results
Mice with selective deletion of AR (ARKO) from vascular smooth muscle cells (SM-ARKO),
endothelial cells (VE-ARKO), or both (SM/VE-ARKO) were compared with wild type (WT)
controls. Hindlimb ischaemia was induced in these mice by ligation and removal of the femo-
ral artery. Post-operative reperfusion was reduced in SM-ARKO and SM/VE-ARKOmice.
Immunohistochemistry indicated that this was accompanied by a reduced density of smooth
muscle actin-positive vessels but no change in the density of isolectin B4-positive vessels in
the gastrocnemius muscle. Deletion of AR from the endothelium (VE-ARKO) did not alter
post-operative reperfusion or vessel density. In an ex vivo (aortic ring culture) model of angio-
genesis, AR was not detected in vascular outgrowths and angiogenesis was not altered by
vascular ARKO or by exposure to dihydrotestosterone (DHT 10−10–10-7M; 6 days).
Conclusion
These results suggest that loss of AR from vascular smooth muscle, but not from the endothe-
lium, contributes to impaired reperfusion in the ischaemic hindlimb of G-ARKO. Impaired reper-
fusion was associated with reduced collateral formation rather than reduced angiogenesis.
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Introduction
Global androgen receptor (AR) knockout (G-ARKO) in mice was recently shown to inhibit
reperfusion in the ischaemic hindlimb, a model that involves both angiogenesis (endothelial
sprouting and formation of new capillaries) and arteriogenesis (growth of pre-existing small
collateral arteries/arterioles; also known as collateral growth) [1]. This impaired reperfusion
was linked to reduced angiogenesis since it was associated with lower vascular density in hin-
dlimb muscles [1]. Consistent with this proposal, G-ARKO was also shown to inhibit angio-
genesis using in vivo (silicon tube implantation) and ex vivo (aortic ring culture) models [1].
However, AR is widely expressed and these investigations did not determine whether the influ-
ence of AR on angiogenesis was associated with a particular cell population. Furthermore,
interpretation of these results was complicated by the systemic effects of global androgen defi-
ciency [2,3].
AR is present in cells of the vascular wall, with expression reported in cultured endothelial
(EC) and smooth muscle (SMC) cells [4–6]. Therefore, since ECs have a central role in the for-
mation of new vascular networks, it has been proposed that androgen regulates angiogenesis
via direct stimulation of AR in ECs [7]. This suggestion was supported by the report that
administration of the non-aromatisable AR agonist dihydrotestosterone (DHT) reversed
impaired hindlimb reperfusion in castrated male mice [7]. This effect was attributed to AR-
induced promotion of EC angiogenesis, based on the observations that DHT promoted AR-
dependent migration and angiogenesis in human umbilical vein endothelial cells (HUVECs)
[7]. However, in the in vivo experiments described by Sieveking et al. [7], it was not possible to
determine whether the increased angiogenesis and restored hindlimb reperfusion stimulated
by DHT were mediated by AR in the vasculature.
We recently described generation, using the cre-loxP system, of a novel murine model of
vascular cell-specific ARKO [5]. This line produces mice with selective deletion of AR from the
vascular ECs (VE-ARKO), SMCs (SM-ARKO) or from both ECs and SMCs (SM/VE-ARKO),
as well as littermate controls. Unlike G-ARKO, vascular ARKO mice have normal testicular
development and normal circulating testosterone levels, thus avoiding the systemic side-effects
of global androgen deficiency, such as low circulating androgen/oestrogen, altered lipid profile
and impaired muscle development [2,3,5]. Here we used our vascular cell-specific ARKO mice
to address the hypothesis that the impaired reperfusion reported in G-ARKOmice [1] is caused
by the loss of AR from vascular cells.
Methods
Mice
Animal experiments were performed in accordance both with Directive 2010/63/EU of the
European Parliament and with the UK Home Office Animal (Scientific Procedures) Act 1986,
and licensed under Project Licence PPL 60/4523. All procedures were approved by the Univer-
sity of Edinburgh ethical review committee (Animal welfare and Ethical review body).
Mice with selective deletion of AR from SMC (SM-ARKO), EC (VE-ARKO) or both cell
types (SM/VE-ARKO) were established in our laboratory, as previously described [5]. All
transgenic mice were of C57BL/6J background. Cell-specific ablation of the Ar gene has been
thoroughly examined and confirmed in freshly isolated aortic endothelial cells and smooth
muscle cells from all of the four genotypes [5]. Routine genotyping of stock mice was carried
out by examining the inheritance of Cre recombinase [5]. Briefly, genomic DNA was extracted
from a frozen ear clip from each mouse. Primers CGCATAACCAGTGAAACAGCATTGC
and CCCTGTGCTCAGACAGAAATGAGA were used for Tie2-cre [8]; and primers
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CGCATAACCAGTGAAACAGCATTGC and CAGACACCGAAGCTACTCTCCTTCC for
SM22-cre [9]. PCR amplification products were resolved using a QiaXcel capillary system
(Qiagen, UK). An amplicon of 608 bp indicated inheritance of the Cre Recombinase transgene
in EC under control of the Tie2 promoter, whilst an amplicon of 575 bp indicated presence of
the Cre Recombinase transgene in SMC under control of the SM22 promoter.
Only male mice (18.2±0.5 weeks old) were used in this study. Mice (3-5/ group) were main-
tained at 21±2°C, 50% humidity, and a 12 hour light/dark cycle with ad libitum access to chow
and water.
Hindlimb ischaemia model and laser Doppler imaging
Unilateral hindlimb ischaemia was introduced by femoral artery ligation, as previously
described [10]. Briefly, mice were anesthetized by inhalation of isoflurane (5% for induction
and 2–3% for maintenance) with appropriate analgesic cover (buprenorphine; 0.05mg/kg body
weight, s.c.). Depth of anaesthesia was indicated by loss of the pedal withdrawal reflex. The
femoral artery in the left leg was carefully dissected and ligated distal to the inguinal ligament
and proximal to the saphenous/popliteal bifurcation. The ligated artery segment was then
excised. Wounds were sutured (6–0 Mersilk) and mice were allowed to recover for 21 days.
Hindlimb blood flow in the foot pad was measured with a Moor Infrared Laser Doppler Imager
(Moor Instruments, UK) immediately before and after femoral artery ligation as well as 3, 7, 14
and 21 days after surgery. To control the variation of systemic perfusion caused by handling
stress and fluctuation of body temperature in individual mice, blood perfusion in the food pad
(the mean signal intensity of the selected area) was normalised to perfusion in the tail.
Histology and immunostaining
For histology and quantitative PCR, mice were culled, by asphyxiation in CO2, 21 days follow-
ing induction of hindlimb ischaemia. The gastrocnemius muscle was harvested both from
ischaemic and control legs. Each muscle was cut into two pieces. One half was frozen at -80°C
and the other half fixed in 10% neutral buffered formalin for 24 hours and embedded in paraf-
fin. Cross-sections from the middle of the muscle were used for haematoxylin and eosin stain-
ing. Total vessels (Isolectin B4 (IB4), Life Technologies; or anti-CD31 antibody, Abcam) and
mature arteries/veins (anti-smooth muscle alpha-actin antibody (SMA), Sigma) were identified
by immunostaining on serial sections. To quantify the vessel density, a whole cross-section of
gastrocnemius muscle was tile-scanned at x200 magnification (Slide scanner Axio Scan.Z1,
Zeiss). The effective muscle areas subject to quantitative analysis were 14.0±0.6 mm2 for each
mouse. The muscle area and vessel density were quantified using Fiji and Image-pro plus 7.0
software (MediaCybernetics, UK). The presence of AR in the vasculature and skeletal muscle
was identified by immunostaining using anti-AR antibody (Santa Cruz, USA), and imaged by
confocal microscopy.
Whole mount immuno-staining was used for samples from the aortic ring assay. Each colla-
gen gel with the aortic ring was fixed in situ by adding ice-cold zinc formalin fixative (100xl:
Sigma) for 30 minutes. The sample was permeabilised with phosphate-buffered saline (PBS)
containing 0.25% (vol/vol) Triton X-100 (Sigma) for 2x15 minutes. The primary antibodies
(for AR and SMA) were added directly into the 96-well plate and incubated overnight at 4°C.
Visualization was achieved by incubation with secondary antibodies conjugated with appropri-
ate fluorescent dyes for 1 hour at room temperature and counter-stained with DAPI. The
whole piece of collagen gel was then carefully mobilised and mounted on a glass side with
Mountant PermaFluor (Thermo Scientific). A cover slip placed on top of the gel with very gen-
tle pressure. Slides were stored at 4°C before imaging.
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Aortic ring assay
Ex vivo angiogenesis was tested using the aortic ring assay, as previously described [11]. Briefly,
mice were culled by asphyxiation in CO2 and the thoracic aorta was isolated. The descending
thoracic aorta from all four genotypes were cut into 15 rings and each ring was embedded in
100μl of collagen gel (1% collagen in Opti-MEM) in a 96-well plate. 200μl of Opti-MEM
(Gibco, cat. no. 51985–026) containing penicillin-streptomycin and 1% fetal bovine serum
(FBS) was added onto the gel. Culture media were changed every 3 days. Dihydrotestosterone
(DHT, Sigma, cat. No. A8380) was dissolved in ethanol and diluted to the designated concen-
tration using culture medium. The final concentration of ethanol was less than 0.01% vol/vol.
Exposures were performed in triplicate. The number of tube-like structures in each well was
manually counted on day 6.
Statistics
Data were expressed as mean ± standard error of the mean (SEM) where n refers to the number
of mice. Data between two groups were analysed using unpaired Student’s t-test. Data from
multiple groups were analysed using one-way or two-way ANOVA with Tukey’s post hoc test,
as appropriate. Statistical analyses were performed using GraphPad Prism v6.04. Differences
were considered significant when p<0.05.
Results
Selective deletion of smooth muscle AR impairs hindlimb reperfusion
following femoral artery ligation
To investigate the role of vascular AR on in vivo recovery of blood perfusion in the ischaemic
hindlimb, we employed a mouse model of femoral artery ligation. Baseline blood flow (pre-sur-
gery) in the mouse hindlimb was not altered by selective deletion of vascular AR (Fig 1), sug-
gesting that vascular ARKO does not alter normal vascular development in the hindlimb.
Femoral artery ligation induced a consistent rapid reduction of blood flow in the foot in all
genotypes (Fig 1).
In WT mice femoral artery removal was followed by a gradual recovery of perfusion in the
foot during the 1st week following surgery. Recovery accelerated in the 2nd week, and stabilised
during the 3rd week (Fig 2). A similar pattern was seen in VE-ARKO mice (Fig 2). In contrast,
both SM-ARKO and SM/VE-ARKO demonstrated a blunted recovery especially in the 2nd
week following surgery. Consequently, both SM-ARKO and SM/VE-ARKO showed impaired
reperfusion at day 14, which remained evident in the SM/VE-ARKO at day 21 (Fig 2; two-way
ANOVA, p<0.01).
The impact of vascular ARKO on post-ischaemic revascularization in the
hindlimb
To determine whether the altered reperfusion was a consequence of increased angiogenesis or
arteriogenesis in the ischaemic tissue, we examined vascular density in the ischaemic gastroc-
nemius muscle. In gastrocnemius muscles isolated 21 days following surgery, immunostaining
by IB4 identified structures (arteries, veins, capillaries) with an EC layer (Fig 3A). Immunos-
taining against SMA identified medial smooth muscle in mature arteries and veins (Fig 3A).
The density of IB4-positive vessels in gastrocnemius muscle from the contralateral unin-
jured (Control) hindlimb was similar in wild type and vascular ARKO mice (Fig 3B). Hindlimb
ischaemia induced a similar increase in IB4 positive vessel density in all groups (Fig 3B).
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The density of SMA-positive vessels in gastrocnemius muscle from the contralateral unin-
jured (Control) hindlimb was also similar in wild type and vascular ARKO mice (Fig 3C).
Induction of ischaemia increased the density of SMA-positive vessels in the gastrocnemius of
WT mice (Fig 3C). This increase was not altered in VE-ARKO mice but was abolished by
SM-ARKO or SM/VE-ARKO (Fig 3C).
Induction of ischaemia significantly up-regulated mRNA expression levels of several ischae-
mia/angiogenesis-related genes (Pdgfrb, Pecam1, Cdh5, Vwf,Hif1a, and Thbs1), but did not
alter expression of Vegfa, in gastrocnemius muscles 21 days following surgery. Expression of
these genes was not altered by vascular ARKO (S1 Fig).
Immunohistologial detection of AR in vasculature of gastrocnemius
To establish the reason for the cell-specific response to ARKO in hindlimb ischaemia, we
examined AR expression in the ischaemic gastrocnemius muscle. AR was identified in SMCs
and some perivascular cells in ischaemic gastrocnemius muscle fromWT and VE-ARKO, but
not from SM-ARKO and SM/VE-ARKO (Fig 4A). AR was not observed on the luminal side of
vessels in any of the genotypes (Fig 4A), indicating lack of AR expression in vascular endothe-
lium in vivo. This was confirmed by double staining against AR and CD31 in ischaemic WT
gastrocnemius muscle (Fig 4B). Vascular ARKO had little impact on the AR expression in skel-
etal muscle (S2 Fig) and did not alter the level of muscle injury in the ischaemic hindlimb by
day 21 (S3 Fig).
Fig 1. Impact of vascular AR deletion on pre- and post-operative hindlimb perfusion. (A) Laser Doppler was used to monitor perfusion of the foot pad
immediately before and after femoral artery ligation, which was quantified by software and normalised to tail. (Areas of interest are indicated by yellow boxes.
The grey area is excluded by software automatically.) (B) Perfusion in the un-operated hindlimb was unaffected by selective deletion of vascular AR. Femoral
artery removal produced a dramatic reduction in hindlimb perfusion that was similar in wild type and ARKOmice. ** p<0.01 compared with corresponding
pre-operative measurements (n = 14–16).
doi:10.1371/journal.pone.0154987.g001
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Androgen action on ex vivo angiogenesis
To clarify the net contribution of vascular AR in regulation of angiogenesis without the con-
founder of arteriogenesis, we employed an ex vivo aortic ring assay of angiogenesis. FBS (1% in
Opti-MEM) stimulated EC sprouting and formation of tube-like structures in aortic rings from
WTmice (Fig 5A). Immunohistochemistry demonstrated AR expression was only detectable
in some perivascular cells but not in the tubule structure (Fig 5B). Vascular cell-specific ARKO
did not alter tube-like structure formation (Fig 5C). Exposure to DHT did not promote tube-
like structure formation in aortas fromWT or vascular ARKO mice (Fig 5C), despite inducing
AR expression in some perivascular cells (Fig 5B).
Discussion
Recent evidence suggests androgen improves reperfusion in ischaemic disease, although the
precise mechanism remains unclear [1,7]. This study addressed the hypothesis that direct acti-
vation of vascular AR regulates post-ischaemic revascularization and reperfusion. By applying
a combination of in vivo and ex vivo approaches to mice with vascular cell selective ARKO, we
were able to show that deletion of AR from SMC suppressed post-ischaemic reperfusion, due
to impaired arteriogenesis. Deletion of AR from the endothelium had little effect on post-
ischaemic angiogenesis either in vivo or ex vivo.
Fig 2. Deletion of AR from smoothmuscle, but not from endothelium, reduced post-operative reperfusion of the ischaemic hindlimb. (A) Laser
Doppler imaging demonstrated partial restoration of hindlimb perfusion over 21 days following femoral artery removal. The blood flow in the foot pad was
quantified and normalised to flow in the tail. (Areas of interest are indicated by yellow boxes. The grey area is excluded by software automatically.) (B)
Deletion of AR from smooth muscle impaired this recovery, whereas deletion of AR from endothelial cells did not. $ p<0.01 difference among genotypes; *
p<0.01 versusWT; # p<0.01 versus VE-ARKO. Data were analysed by two way ANOVA plus Tukey post hoc test (n = 14–16).
doi:10.1371/journal.pone.0154987.g002
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Previous studies demonstrated that androgen depletion (by castration) or G-ARKO
impaired reperfusion in hindlimb ischaemia [1,7]. However, due to the important role of AR in
skeletal muscle [3,12–16], over 50% G-ARKO ischaemic legs developed autoamputation by
day 21, but none in WT [1]. The impaired reperfusion in G-ARKO, therefore, cannot be simply
explained by decreased angiogenesis.
The generation of mice with vascular ARKO [5] allowed direct determination of the role of
vascular AR in post-ischaemia revascularization, without the systemic complications seen in
castrated or G-ARKO mice. Vascular ARKO did not affect AR expression in skeletal muscle
and ischaemia-induced muscle injury. Thus, these mice provide a viable model for investigat-
ing the role of AR in vascular remodelling.
Direct evidence of AR expression in vascular endothelium in vivo is very limited. Our previ-
ous data demonstrated that AR was sporadically expressed in mouse aortic endothelium [5].
AR was undetectable (by immunostaining) in the endothelium of smaller vessels, including
femoral artery, mesenteric artery and capillaries (data not shown). Consistent with these obser-
vations, AR expression was not detected in newly formed endothelial tubules in the aortic ring
assay (with or without DHT), nor in the neovasculature in ischaemic hindlimbs. Therefore, it
is not surprising that VE-ARKO had no impact on angiogenesis in either ex vivo or in vivo
models.
SMCs (SMA-positive) are known to play a critical role in post-angiogenic vascular remodel-
ling and initiation of blood perfusion [17,18]. Further development of microvessels into con-
ductance vessels or growth of collateral vessels, defined as arteriogenesis, are important
mechanisms for reperfusion of ischaemic tissue [19]. Notably, successful post-angiogenesis
remodelling can induce a 60% reduction in neo-vascular density to form a mature vascular net-
work [17,20]. Our previous and current studies demonstrated that SMCs constitutively express
AR in vivo and in vitro [5]. Deletion of AR from SMCs suppressed the formation of SMA-posi-
tive vessels, suggesting an interruption of arteriogenesis. The persistence of impaired reperfu-
sion suggested that the IB4-postive SMA-negative microvessels are inefficient in conducting
blood to remote ischaemic tissue (mouse food pad). Whatever the mechanism, these results
suggests that arteriogenesis mediated by AR in SMCs is important for successful hindlimb
reperfusion. It is also possible that deletion of AR from SM could reduce hindlimb perfusion by
altering vascular contractility. In our previous investigation, however, we demonstrated that
arterial contraction in response to adrenoceptor agonists was reduced in SM-ARKOmice,
which would predict greater perfusion [5]. Further studies are required to determine the mech-
anisms underpinning regulation of arteriogenesis by AR in SMCs.
Yoshida et al. demonstrated an early rise (day 1) in Vegfa expression in G-ARKO ischaemic
hindlimb, suggesting a maintained local angiogenic response [1]. Our results extend this obser-
vation, indicating that deletion of vascular AR does not impair angiogenesis. However, induc-
tion of angiogenesis does not necessarily predict improvement in reperfusion. In order to
deliver blood to the ischaemic tissue, neovasculature requires extensive remodelling [17,18,20].
VEGF alone is not sufficient to drive neovascular maturation and arteriogenesis [21]. This was
reflected by the failure of clinical trials using VEGF-based therapies aiming to improve post-
Fig 3. AR deletion from vascular smoothmuscle, but not from endothelial cells, altered vascular density in ischaemic
gastrocnemius. (A) Detection of endothelial cells (IB4-positive) and smooth muscle cells (SMA-positive) in vascular structures was
achieved using immunohistochemistry on cross-sections of gastrocnemius muscle. High resolution tile-scanning (@ x200) using slide
scanner Axio Scan.Z1 (Zeiss) allowed quantification of vascular phenotype and density of the whole muscle section. (B) Quantitation of
vessel density indicated that deletion of AR from neither vascular smooth muscle nor endothelium altered the rise in density of IB4-positive
vessels in ischaemic hindlimb. **, p<0.01 by two way ANOVA. (C) Deletion of AR from vascular smooth muscle, but not endothelium,
prevented the ischaemia-induced increase in SMA-positive vessels. * p<0.05; ** p<0.01; by two way ANOVA plus Tukey post hoc test. ##
P<0.01, by Student’s t-test (n = 7–10).
doi:10.1371/journal.pone.0154987.g003
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ischaemic myocardial perfusion or reduce lower limb amputation rate [22]. Additional factors,
such as PDGF-B, have a role in recruitment of SMCs/pericytes to stabilise neovasculature and
support further arteriogenesis [23–25]. Further investigation is required to clarify whether
androgen signalling interacts with PDGF-B signalling in regulation of SMC/pericyte function
in arteriogenesis. Interestingly, Peng et al. recently reported a male advantage in mouse hin-
dlimb ischaemia where post-ischaemia arteriogenesis was higher in males than in females [26].
This study opens the possibility that an increase in circulating androgen levels may exert thera-
peutic value for hindlimb ischaemia.
In conclusion, this investigation has demonstrated that AR expression in vascular endothe-
lium is undetectable and makes little contribution to the androgen-dependent regulation of
Fig 4. Localisation of vascular ARKO in murine ischaemic gastrocnemius. (A) AR was detected in the vascular smooth muscle
(AR = green, SMA = red, DAPI = blue) in the ischaemic gastrocnemius muscle at day 21 fromWT and VE-ARKO, but not SM-ARKO and
SM/VEARKO. No positive staining of AR could be identified on the luminal (endothelial) side of the vessel in any genotypes. (Yellow
arrows indicate AR-positive nuclei) (B) Double staining of AR and CD31 in WT confirmed that AR was not expressed in vascular
endothelium in the ischaemic hindlimb. (White arrows indicate nuclei of endothelial cells.) Some AR positive cells were also found in the
perivascular connective tissue.
doi:10.1371/journal.pone.0154987.g004
Fig 5. Androgen signalling did not regulate ex vivo angiogenesis in the aortic ring assay. Descending thoracic aorta were from all four genotypes were
freshly dissected, cut into aortic rings and embedded in collagen gel. Endothelial cell sprouting and tube-like structure formation was stimulated by culture
medium with 1% FBS. Tube-like structures were counted manually at day 6. (A) Representative phase-contrast image of tube-like structure (arrows) growing
from aWT aortic ring. (B) Representative images of AR expression in tube-like structure fromWT aortic rings with/without DHT treatment. Yellow lines
highlight a tube-like structure. (C) Neither DHT nor vascular ARKO significantly altered angiogenesis in the aortic ring assay (By two way ANOVA). VEGF
(5ng/ml) treatment in WT rings served as positive control for maximum angiogenesis (*, p<0.01 by Student's t-test). Exposures were performed in triplicates,
and repeated 6 times, with the exception of the VEGF group, which was repeated 4 times.
doi:10.1371/journal.pone.0154987.g005
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ischaemia-induced angiogenesis. Instead, AR expression in vascular smooth muscle regulates
reperfusion of the foot following induction of ischaemia. This suggests that androgen-mediated
arteriogenesis makes a significant contribution to recovery from ischaemia. This is the first
study to identify the key role of smooth muscle cell AR in regulation of androgen-mediated
arteriogenesis, which may in part explain why being male is an advantage in terms of response
to ischaemia. These results also have relevance to our understanding of the likely benefit of
androgen replacement therapy in patients with ischaemic disease.
Supporting Information
S1 Fig. mRNA expression profile in the gastrocnemius muscles at day21.mRNA expression
was normalised to Gapdh.  p<0.05 control versus ischaemic, by two way ANOVA. Induction
of ischaemia increased transcript number of (A) Pecam-1, (B) Cdh5, (C) Vwf, (D) Hif1a, and
(E) Thbs1, but not (F) Vegfa. Selective deletion of vascular ARKO did not alter gene expression
in control or ischaemic tissues (n = 6–10).
(TIF)
S2 Fig. AR expression in the ischaemic gastrocnemius muscle in WT (A) and SM/
VE-ARKO (B) mice at day 21. AR expression in the ischaemic gastrocnemius muscle was not
affected by vascular ARKO. AR = green; DAPI = Blue.
(TIF)
S3 Fig. Vascular ARKO had no effect on muscular injury in ischaemic hindlimb. (A) H&E
staining of a cross-section of the gastrocnemius muscle demonstrated intra-muscular adipo-
cytes (arrows) replacing the damaged muscle fibres in the ischaemic hindlimb. (B) Oil red O
staining confirmed the presence of lipid-filled adipocytes (arrows) in the ischaemic muscles.
(C) The percentage area of intra-muscular adipocytes was quantified using Image-pro plus 7.0.




S1 Table. qPCR primers used in this study.
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